A massive thank you to all our Peer Reviewers in 2024
Cell & Gene Therapy Insights 2024; 10(11), 1608
10.18609/cgti.2024.185
.gif)
At BioInsights, we use double-blinded peer review to minimize bias and focus the evaluation solely on the quality of the research rather than personal identities. However, despite their invaluable expertise and thoughtful feedback, peer reviewers often go unrecognized and are not formally acknowledged in publications. Their contributions are crucial to our editorial process, helping us assess articles and advance fields such as cell and gene therapy, nucleic acids, vaccines, and immuno-oncology, and we deeply appreciate the time and effort our reviewers dedicate to this process, enabling us to publish content of the highest quality. To honor their contributions, the Editors of BioInsights are proud to publicly acknowledge our top reviewers of 2024, and we look forward to collaborating with them in the future.
Sincerely,
BioInsights
Dr Asher Williams, Columbia University Dr Joseph Zaia, Department of Biochemistry, Boston University School of Medicine Dr Hemant Dhamne, Autolus Ltd Dr Eduard Ayuso, Dinaqor AG Dr Hassan Rashidi, University College London Dr Davide Danovi, bit.bio Dr Brian Philip, National Institute for Bioprocessing Research and Training (NIBRT) Dr Saba Ghassemi, University of Pennsylvania School of Medicine Dr Austin Thiel, Elevate Bio Dr Wouter Van’t Hof, Cleveland Cord Blood Center Dr Roger Horton, Anthony Nolan Dr Jason Acker, University of Alberta Dr Kavitha Siva, Xintela AB Dr Victoria Day, NHS Blood and Transplant Dr Roberto Gramignoli, IRCCS Ospedale Pediatrico Giannina Gaslini Dr Nick Chen, Fate Therapeutics Dr Behnam Ahmadian Baghbaderani, Cell Therapy Process Department, Lonza Houston Dr Daniel Paull, The New York Stem Cell Foundation Research Institute Dr Dhruv Sareen, Cedars-Sinai Dr Marina Zenkova, Institute of Chemical Biology and Fundamental Medicine SB RAS Dr Tonya Villafana, AstraZeneca Dr Jean Haensler, Sanofi R&D Dr Eleni Samaridou, Merck Dr Michaela Sharpe, Moare Solutions Ltd Mr Paul Heal, Orchard Therapeutics Dr James McBlane, Licensing Division, Medicines and Healthcare Products Regulatory Agency Dr Keith Sutton, Resolution Therapeutics Dr Michela Palmisano, Fondazione Telethon Dr Sol Ruiz Antunez, Spanish Medicines Agency (AEMPS) Dr Pasi Virta, University of Turku Finland Dr Alyssa Hill, Oxford Department of Pediatrics Dr Ramon Eritja, Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC), Dr Akash Bhattacharya, Beckman Coulter Life Sciences Dr Bryan Troxell, Atsena Therapeutics Dr Cristiana Boi, North Carolina State University Dr Vijesh Kumar, Spark Therapeutics Dr Lefkothea Papadopoulou, Laboratory of Pharmacology, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki Dr Benjamin Davis, University of Pennsylvania Dr Jose-Antonio Daros, Instituto de Biología Molecular y Celular de Plantas Dr Simon Daniel, Imperial College London Dr Kostadinka Lilova, Autolus Therapeutics Dr David Shaw, Genentech Dr Sudhanshu Shekhar, Bristol Myers Squibb Dr Sameer Kalghatgi, FUJIFILM Diosynth Biotechnologies Mr David Ede, Sartorius Dr Stuart Beattie, Biogen Dr Chantelle Gaskin, Thermo Fisher Scientific Dr Alexis Cockroft, Lex Regulatory Ltd Dr Ilona Reischl, Austrian Agency for Health and Food Safety—Austrian Medicines and Medical Devices Agency Dr Nermin Ibreljic, Sarepta Therapeutics Dr Alex Chatel, Donaldson Dr Paul Young, Pharmaron Gene Therapy Dr Francesca Vitelli, Intellia Therapeutics Dr Rowan Flynn, RosalinCT Dr Emily Titus, Notch Therapeutics Dr Pete Tonge, bit.bio Dr David Wellis, Excellos Dr Isabelle Riviere, Takeda Dr Jennifer Solomon, STEMCELL Technologies Inc. Dr Saif Raisheed, Biocina Dr Rana Chattopadhyay, Sanofi Mr Benjamin Hall, Tessera Therapeutics Dr Monica Dommel, Curevac Dr Jane Luo, sciex Dr Wei He, Lawrence Livermore National Laboratory Dr Renaud Heine, Erasmus School of Health Policy and Management, Erasmus University Mr Vikram Shanbhag, SG Analytics Dr Misganaw Asmamaw Mengstie, Debre Tabor University Dr Riccardo Privolizzi, Sania Therapeutics Dr Anjulika Chawla, University College London Dr Sourav Choudhury, Sanofi Dr Adrien Lemoine, Bloomsbury Genetic Therapies Dr Luca Marchetti, University of Trento Centre for Computational and Systems Biology (COSBI) Dr Atul Goyal, Pfizer Dr Sita Awasthi, Perelman School of Medicine, University of Pennsylvania Dr Matthew Smart, Cell and Gene Therapy Catapult Dr Kevin D’Amour, Stemson Therapeutics Dr Tessy Hick, Umeå University Mr Ashish Saksule, Vertex Pharmaceuticals Dr Sharada Mokkapati, MD Anderson Cancer Center Ms Min Zong, Cellics Therapeutics | Mr Daniel Koback, Sartorius Mr Yannick Borkens, Charité—Universitätsmedizin Berlin Dr Kazutoyo Miura, National Institute of Allergy and Infectious Diseases (NIAID) Dr Rajender Jena, Serum Institute of India Pvt. Ltd Dr Piotr Kowalski, School of Pharmacy, University College Cork Dr Natalie Prow, The Hull York Medical School, University of York Dr Ruben Esse, Cell and Gene Therapy Catapult Ms Konstantina Malengou, Cellics Therapeutics Dr Ferdos Hashi, King’s College London Mr Paul Greback-Clarke, AskBio Mr Kyle Stead, Virocell Biologics Dr Gabrielle Humphrey, VECTAPLUS Dr Catherine Jomary, IPS-Integrated Project Services Professor Barry Fuller, University College London Dr Julie Meneghel, Cytiva Dr Kathryn Murray, Takara Bio Europe Mr Alexander Kerr, King’s College London Dr Maria Rende, Sartorius Dr Drew Hope, Exmoor Pharma Dr Garima Thakur, Regeneron Dr Adrien Savy, Coave Therapeutics Dr John F Tisdale, Cellular and Molecular Therapeutics, NIH Dr Samantha Scaramuzza, San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) Dr Clare Blue, Exmoor Pharma Mr Shashank Mishra, Batavia Biosciences Dr Stefan Marsden, Batavia Biosciences Dr Lionel Galibert, AbbVie Dr Jelena Ruscic, Quell Therapeutics Dr Christopher Perry, Rentschler Biopharma Dr Natalie Francis, King’s College London Mr Derrick Houser, UCSF Ms Sarah Callens, CCRM Nordic Dr Sam Denby, Biofrey Prof Stephen Kent, The Peter Doherty Institute, University of Melbourne Dr Sabada Dube, AstraZeneca Dr Edward Parker, University College London Mr Julien Browne, Quell Therapeutics Dr Ilaria Santeramo, Resolution Therapeutics Dr Claire Horlock, OriBiotech Dr Panteli Theocharous, Garuda Therapeutics Dr Rajeev Rai, University College London Dr Jennifer Harbottle, AstraZeneca Dr Ruxandra Comisel, University College London Dr Andrew Zydney, Penn State University Mr Laurens Vergauwen, Merck Dr Cordin Arpagaus, OST Mr Zunaid Shaikh, Nova Laboratories Limited Dr Ketki Vispute, Autolus Dr John Garcia, University College London Dr Mustafa Turkoz, Turn Biotechnologies Dr Giulia Lambiase, AstraZeneca Ms Jessica Weaver, BioAgilytix Mr Michael Dullen, Ultragenyx Ms Sadia L’Baouch, JCR Pharmaceuticals Co Ltd Ms Miriam Sarkis, Imperial Dr Matthias Hebben, Complement Therapeutics Dr Angga Kusuma, UniQure Dr Olaniyi Olarewaju, Boehringer Ingelheim Dr Claudio Mussolino, Institute for Transfusion Medicine and Gene Therapy—University Medical Center Freiburg Mr Deividas Pazeraitis, AstraZeneca Dr Jos Weusten, MSD, Center for Mathematical Sciences Dr Warren Roche, Sanofi Mr Yannick Van Haelst, Sanofi Dr Stan Altan, Johnson & Johnson Dr Darren Kamikura, Bristol Myers Squibb Mr Raymond Luke, Verismo Therapeutics Dr Eleanna Kaffe, University of Pennsylvania Dr Francis Combes, SINTEF Industry Dr Keming Zhou, Qilu Pharmaceuticals Dr Vinod Vathipadiekal, Alloy Therapeutics Dr Elnaz Harifi Mood, Bavarian Nordic Dr Sonja Marjanovic, RAND Europe Mr Daniel Gibson, Cell and Gene Therapy Catapult Dr Pranav Joshi, University of Pennsylvania Dr Valeria Mastrullo, Cytiva Dr Suriyasri Subramanian, AstraZeneca Dr Nuria Gomez Santos, Catalent Pharma Solutions Mr Christian Fuchs, Genentech Ms Donna Rill, Triumvira Immunologics Dr Christiane Niederlaender, Parexel Dr Carl Simon, National Institute of Standards and Technology Dr Uma Lakshmipathy, Thermo Fisher Scientific Dr Seshu Tyagarajan, Candel Therapeutics |